Work

Figure S4 from RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer

Year: 2023

Type: other

Abstract: Figure S4. 1,000 HT29 NSC and shRac1b cells were plated in a 96-well plate and treated with different doses of 5FU for 10 days. On day 10, cell viability was analyzed using the PrestoBlue reagent according to the manufacturers instructions. Data was graphed using GraphPad software and IC50 values were generated using the log(inhibitor) vs. response - variable slope function. Data represents quadruplicates and the error bars represent the 95% confidence intervals.

DOI: 10.1158/1535-7163.22510684

Authors: Erik T. Goka, Pallavi Chaturvedi, Dayrelis T. Mesa Lopez, Adriana De La Garza, Marc E. Lippman

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362535502

Cites:

Cited by:

Related to: 10